Many have wanted the data - and the final publication for the Nitazoxanide for Norovirus in Transplants Study is out! Time to stop using nitazoxanide for norovirus - zero impact on virology, no impact on clinical outcomes and clear financial toxicity. pubmed.ncbi.nlm.nih.gov/42177030/

ESGICH is trying to learn about what local/regional Immunocompromised Host ID Networks that hold meetings to share challenging cases or other info. If you participate in these or don’t have access to one and would want to - please complete the survey. forms.gle/jTUoweU1ebu8...

On behalf of the TID section of TTS, ESGICH and the @thetxidjournal.bsky.social we invite you to: ESGICH – CPC Webinar: Thursday, April 9, 2026, at 14:00 CET

A Neglected Tropical Disease Beyond Endemic Borders: A Case-Based Discussion Registration link: us06web.zoom.us/webinar/regi...

Submit Ideas for Potential ESGICH Sessions at ESCMID Global 2027: If you have ideas for sessions, even if attend the in person meeting, please submit the ideas online . You can submit ideas by close of business April 17 via this link: forms.gle/ecb4ZrJkK9F3... 3/3

Participate in the Session Brainstorming Session: Sunday April 19 at 10:30am – 12:30pm in ICM 2nd Floor, Ostersee Room. A Zoom link will be shared shortly. If you want to participate in this session, please sign up using this link: forms.gle/vNnPYFuifXUH... 2/3

ESGICH is seeking help in developing proposals for @escmid.bsky.social Global 2027. We are seeking participation in a brainstorming session in Munich April 19 10:30am - 12:30pm in Ostersee Room, 2nd Floor of the ICM. We are also seeking ideas for sessions. See next tweets w/ details 1/3

ESGICH is seeking help in developing proposals for @escmid.bsky.social Global 2027. We are seeking participation in a brainstorming session in Munich April 19 10:30am - 12:30pm in Ostersee Room, 2nd Floor of the ICM. We are also seeking ideas for sessions. See next tweets w/ details 1/3

3 years ago, I was in the Community of Leaders group and can say it had such a huge impact on how I lead - I recommend this to anyone who wants to be a more engaged and effective leader! Time well spent!

First human #H5N1 case of 2026 in #Cambodia: a 30-year-old man from Kampot province. Sequencing, virus isolation & animal investigations ongoing. Dead chicken at home before onset. Patient has since recovered. 🦠💉😷🐓🥼🔬🧪 Sequencing, contact tracing, and poultry investigations ongoing.

Not surprisingly, most adults healthcare-associated respiratory virus infections are immunocompromised and they account for the sickest patients. A key signal to better protect our most vulnerable patients. onlinelibrary.wiley.com/doi/10.1111/...

So happy to see this paper out after a lot of persistence from Shardul Rathod @hannahnam.bsky.social @ucirvine.bsky.social. Over a 10 yr period, 6.6% of Flu cases, 12.2% of RSV cases, and 10.9% of PIV cases were Hosp-Acquired. Most in ICH. onlinelibrary.wiley.com/doi/10.1111/...

I had the HUGE honor of being the 40th Forbes Fellow - when I was the previous awardees, I was truly humbled. The ID community is incredible in Melbourne. @monashuniversity.bsky.social @unimelb.bsky.social @thedohertyinst.bsky.social @trubianojason.bsky.social @bradgardiner.bsky.social

Due to the USG Shutdown, I wasn’t able to attend or present @idweek.bsky.social. I was supposed to give the talk on top viral studies that will impact your practice. Here are the papers I was going to highlight: See next posts

Due to the US Government Shutdown, I will not be able to atted @IDWeek.bsky.social #IDWeek2025. I had worked on my 2 invited talks and so will share them. My first talk was going to be about the epidemiology and clinical course of respiratory viral infections in the immunocompromised.

Excited to see the “Advances in Influenza Therapeutics” supplement out in @jidjournal.bsky.social - led by Fred Hayden and Rich Whitley, this supplement reviews what we know about antivirals and how they should be used for influenza. academic.oup.com/jid/issue/23...

Do you focus on HSCT/Oncology ID? Want to be part of the editorial team of @thetxidjournal.bsky.social? Please apply by October 17 for an open position as outlined in this link!

check out our review of donor-derived infections in heart & lung transplant recipients! was a pleasure working with @michaelisonmd.bsky.social on this! #TxID doi.org/10.1016/j.jh...

The ISRV AVG meeting kicked of by Fred Hayden giving the 2nd Roberts/Tisdale lecture on the clinical implications of antiviral resistance.

Excited to have this paper out! Demonstrates that the recipients of lung 🫁 tx for COVID-Associated Lung Injury (CALI) loose humoral protection and have unique cellular immune responses. www.sciencedirect.com/science/arti...

AJT’S new ID blog, TxIDExchange, is dedicated to sharing the latest ID updates, research, and guidelines relevant to the transplant community. We’re soliciting blog posts and comments from you and your colleagues and encourage you to participate. ajt-transplant-id-exchange.squarespace.com

Don't miss the new @amjtransplant.bsky.social #TxID blog led by Emily Blumberg ajt-transplant-id-exchange.squarespace.com #wtc2025 @ast-idcop.bsky.social @ast-tyfcop.bsky.social @astinfo.bsky.social

Excited to head to San Francisco for #WTC2025 @ast-idcop.bsky.social

Michael Woodward presented on utility of FMT in ICHs - can reduce risk of recurrent C diff and MDRO infections - cost, availability and lack of guidance are limiting application @fredhutch 5th Symposium on ID in ICHs. www.science.org/doi/10.1126/...

Mike Satlin gave an incredible review of MDR-GBR. These challenging bacteria cause freq infections and screening for can inform management of F&N @fredhutch.bsky.social 5th Symposium on ID in ICHs.

Jay Fishman provided the keynote on Xenotransplantation- major progress but many unknowns- thankfully formal clinical trials will help inform optimal approach @fredhutch.bsky.social 5th Symposium on ID in ICHs.

Erika Kampouri provided a masterful review of infections after CAR-T and the impact of CMV and HHV6 in these patients - HHV6 CNS disease rare, CMV needs more data to confirm optimal management. @fredhutch.bsky.social 5th Symposium on ID in ICHs onlinelibrary.wiley.com/doi/10.1111/...

Charles Chiu @UCSF gave an amazing lecture on mNGS in immunocompromised- while helpful, limitations exist and must be recognized to interpret the results.

Amazing talk on aging and infection Maheen Abidi - many questions and need for data to inform management approaches. @fredhutch.bsky.social Symposium of Infections in ICH

Hans Hirsch provided a master class in BKV as the keynote for the 5th @fredhutch.bsky.social Symposium on Infections in ICH. Studies have advanced our understanding of pathogens and management - but many questions remain.

Michael Boeckh highlights the grow of the the @fredhutch Symposium on Infections - matching interest the field of #TxID It’s easy to see why with an expansion of tools to study and apply to improve outcomes in our patients!

Really excited to be a part of this study and see it published today! Efficacy of Baloxavir Treatment in Preventing Transmission of Influenza | New England Journal of Medicine www.nejm.org/doi/full/10....

Adjuvanted RSV profusion F vaccine protection over 3 years - while VE declined over time, there remains significant protection against severe disease. More data is needed for longer term outcomes to inform optimal use.

It was an honor to review the data on the link between Ureaplasma spp and Hyperammonemia in Lung Transplant recipients @ESCMID #ESCMIDGlobal 2025. Slides are here for those who want them. www.dropbox.com/scl/fi/ei4ym...

A true master class on Chagas in transplantation - emerging data supports the safety of using Chagas positive donors with careful monitoring and treatment. Marcelo Radisic #ESCMIDGlobal

Great review of TB in endemic regions including approaches to use universal prophylaxis to reduce the incidence of post-transplant infection. @RubinaNaqvi1

Great talk about HHV8 and the role of donor screening by Alesandra Mularone including follow-up management. linkinghub.elsevier.com/retrieve/pii...

It’s not to late to submit ideas for sessions @escmid.bsky.social Global 2026 for ESGICH to advocate for. Please follow the links below to submit ideas and sign up for the meeting to talk through the ideas!

Really cool study looking at different flu vax formulations for older adults. Those fancy flu vaccines (adjuvanted or higher dose) make a difference. www.eurosurveillance.org/content/10.2...

Early Rx in Influenza is key! While pts may not present to the hospital early after sx onset (median 3.6 days after sx onset), early empiric therapy for influenza is recommended by guidelines supported by a growing literature showing benefit but delays in therapy are common.

If you have ideas for sessions at ESCMID Global 2026 - sign up to be art of the planning group or submit your ideas for sessions.

Please save the date and join us for a dynamic ICHS educational event offering comprehensive scientific programming, insights into cutting-edge research, innovative care practices, and effective management strategies for immunocompromised hosts. For more information please visit, www.ichs.org

Do you have ideas for sessions about infections in immunocompromised hosts for @escmid.bsky.social Global 2026? ESGICH is looking for people to help with session planning and concepts. To participate in the planning: forms.gle/1gAUw3UuBdxk... To submit a concept: forms.gle/SyFjuxnbUuCD...

Do you have ideas for sessions about infections in immunocompromised hosts for @escmid.bsky.social Global 2026? ESGICH is looking for people to help with session planning and concepts. To participate in the planning: forms.gle/1gAUw3UuBdxk... To submit a concept: forms.gle/SyFjuxnbUuCD...

Vaccines are critical for the protection of patients from infection - it was an honor to write this piece discussing the challenges and data needs for use in immunocompromised patients. academic.oup.com/jid/article/...

New editorial in @thetxidjournal.bsky.social from Dr. Carlos Gomez and @drandrekalil.bsky.social: "Briding the Gaps in CMV Management in Transplantation: Lessons from Resource-Limited Settings" #IDSky #TxID onlinelibrary.wiley.com/doi/10.1111/...

🚨Are you a trainee and part of ESGICH with an accepted abstract ESCMID Global 2025?🚨 Submit an application for 1 of 4 500€ awards! Deadline February 28 12am CET docs.google.com/forms/d/e/1F...

🚨Are you a trainee and part of ESGICH with an accepted abstract ESCMID Global 2025?🚨 Submit an application for 1 of 4 500€ awards! Deadline February 28 12am CET docs.google.com/forms/d/e/1F...

📣 New #ESWIAirborne: #hMPV - the (not so) new kid on the block. Learn about the story behind #humanmetapneumovirus and how it was first discovered, featuring: Albert Osterhaus, Bernadette van den Hoogen & Ann Falsey! #ESWIEducationHub shorturl.at/yszOv

‼️Our new paper on social media in #TxID is officially out in @thetxidjournal.bsky.social We summarize findings from our #TxIDChat @txidfellows.bsky.social We discuss recs for trainees, career advancement, & future directions in this changing landscape. Check it out! dx.doi.org/10.1111/tid....